Tonix Pharmaceuticals Holding Corp (TNXP) SEC News Dec. 16, 2025, 12:05 UTC (70% Positive) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Announces Clinical Development Update Full text
Register to leave comments News bot Dec. 16, 2025, 12:07 p.m. 📋 TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) - Clinical Trial Update Filing Date: 2025-12-16 Accepted: 2025-12-16 07:05:37 Event Type: Clinical Trial Update Event Details: Tonix Pharmaceuticals Holding Corp (TNXP) Announces Clinical Trial Update Tonix Pharmaceuticals Holding Corp (TNXP) provided an update on its clinical development programs. Clinical Development Highlights: Updated Timeline: December 16, 2025, 2025-12 💼 Business Developments: No business developments data available. Structured Data: Company Name: Tonix Pharmaceuticals Holding CorpCIK: 0001430306Ticker Symbol: TNXPPeriod End Date: 2025-12-16Document Type: 8-K
📋 TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) - Clinical Trial Update
Filing Date: 2025-12-16
Accepted: 2025-12-16 07:05:37
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
No business developments data available.
Structured Data: